Last updated: July 17, 2026

Application No. 18/684,346

NEXT GENERATION VACCINES COMPRISING ANTIGENIC LIBRARIES AND METHODS OF MAKING AND USING SAME

Non-Final OA

Filed

Feb 16, 2024

Priority

Aug 16, 2021 — provisional 63/233,361 +2 more

Examiner

GILL, RACHEL B

Art Unit

1671

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Duke University

OA Round

1 (Non-Final)

Interview Optional

— +28.0% interview lift. Examiner has a relatively high allowance rate (66%); +28.0% interview lift. A written response may suffice.

Based on 859 resolved cases, 2023–2026

Examiner Intelligence

GILL, RACHEL B View full profile →

Grants 66% — above average

Career Allowance Rate

563 granted / 859 resolved

+5.5% vs TC avg

Strong +28% interview lift

Without

With

+28.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 5m

Avg Prosecution

49 currently pending

Career history

906

Total Applications

across all art units

Statute-Specific Performance

§101

0.9%

-39.1% vs TC avg

§103

40.3%

+0.3% vs TC avg

§102

15.5%

-24.5% vs TC avg

§112

5.8%

-34.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 859 resolved cases

Prosecution Timeline

Feb 16, 2024

Application Filed

Jun 01, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/279,501

Patent 12655447

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES

5y 2m to grant Granted Jun 16, 2026

18/416,835

Patent 12622960

VARICELLA ZOSTER VIRUS (VZV) VACCINE

2y 3m to grant Granted May 12, 2026

17/771,595

Patent 12618839

NOVEL ANTIBODIES FOR DETECTING EPSTEIN BARR VIRUS-POSITIVE GASTRIC CANCER

4y 0m to grant Granted May 05, 2026

17/998,737

Patent 12611454

RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS VIRAL VECTOR

3y 5m to grant Granted Apr 28, 2026

17/714,307

Patent 12605454

MODIFIED VIRUS-LIKE PARTICLES OF CMV

4y 0m to grant Granted Apr 21, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

66%

Grant Probability

94%

With Interview (+28.0%)

2y 5m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 859 resolved cases by this examiner. Grant probability derived from career allowance rate.